A new one has been added to the scandals in the pharmaceutical industry. While many questionable drugs have been released to the market, some statistics are hidden from people. Especially the number of people who die from the side effects of drugs is quite high. Despite this, the alzheimer’s drug Aduhelm, whose research was not fully completed, was approved by the FDA. However, three scientists who found this decision wrong resigned from their duties on the commission.
Scientists in the independent commission established to support the FDA’s Alzheimer’s treatment studies say that the decision to approve the drug was the biggest mistake ever made by the FDA. . After examining the first clinical data presented in November, 10 of the 11 scientists in the independent commission said that the drug should not be approved, while one person voted undecided. Despite this, after the drug was approved, scientists began to resign from their duties in the commission.
Alleged side effects related to Alzheimer’s drug Aduhelm
From their duties According to the resigned scientists, there is insufficient evidence to support the claim that the drug can slow cognitive decline in people in the early stages of the disease. This drug, which has a high price tag of 56 thousand dollars, is not effective enough to be sold at such a price according to the statements. It has effects, but all this was ignored by the FDA and the drug was approved. According to scientists who resigned from their duties on the committee, the approval of such an inadequate and invalid drug blocks the way for new treatment methods to be developed. seems to stay on the agenda.